Financial Ratios

KMS MEDISURGI LTD.

NSE : NABSE : 540468ISIN CODE : INE870V01014Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE125.000 (0 %)
PREV CLOSE ( ) 125.00
OPEN PRICE ( ) 125.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4000
TODAY'S LOW / HIGH ( )125.00 125.00
52 WK LOW / HIGH ( ) 125125
NSE
This Company is not listed in NSE
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)1.381.740.650.370.34
   CEPS(Rs)2.142.701.531.381.57
   DPS(Rs)0.050.050.050.050.05
   Book NAV/Share(Rs)23.2221.8920.2119.5619.23
   Tax Rate(%)24.9013.0024.5448.2138.38
Margin Ratios
   Core EBITDA Margin(%)5.878.965.476.736.40
   EBIT Margin(%)4.736.223.143.602.45
   Pre Tax Margin(%)4.355.972.763.161.76
   PAT Margin (%)3.275.202.091.641.09
   Cash Profit Margin (%)5.088.074.916.055.00
Performance Ratios
   ROA(%)4.465.892.251.331.14
   ROE(%)6.108.253.281.921.78
   ROCE(%)8.018.654.283.623.42
   Asset Turnover(x)1.371.131.080.811.05
   Sales/Fixed Asset(x)2.491.971.981.482.08
   Working Capital/Sales(x)2.211.771.701.291.83
Efficiency Ratios
   Fixed Capital/Sales(x)0.400.510.510.680.48
   Receivable days161.88216.47226.80286.10186.08
   Inventory Days39.5531.2128.8849.0255.76
   Payable days64.0878.5891.39104.27103.19
Valuation Parameters
   PER(x)0.000.0052.8391.5796.92
   PCE(x)0.000.0022.4524.7821.04
   Price/Book(x)0.000.001.701.741.72
   Yield(%)0.150.150.15
   EV/Net Sales(x)0.250.371.161.551.13
   EV/Core EBITDA(x)3.774.0819.4319.3917.77
   EV/EBIT(x)5.205.9736.8843.1246.19
   EV/CE(x)0.420.501.561.561.57
   M Cap / Sales0.000.001.101.501.05
Growth Ratio
   Net Sales Growth(%)25.916.8937.38-27.404.94
   Core EBITDA Growth(%)-9.5363.102.28-8.63-9.14
   EBIT Growth(%)-4.24111.7219.836.77-14.95
   PAT Growth(%)-20.79166.2275.109.36-8.80
   EPS Growth(%)-20.79166.2275.119.37-8.81
Financial Stability Ratios
   Total Debt/Equity(x)0.070.140.150.160.17
   Current Ratio(x)3.375.133.794.144.41
   Quick Ratio(x)2.584.523.353.783.59
   Interest Cover(x)12.4024.608.318.143.57
   Total Debt/Mcap(x)0.090.090.10

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.